Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 5,651 shares at $25.13 ($142K) on 2022-08-18, disclosed to the SEC on 2022-08-22.
Open-market sale of $142k PCVX by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.13 | 2,551 | $64K | 45.0% |
| 2 | $25.13 | 2,551 | $64K | 45.0% |
| 3 | $25.89 | 549 | $14K | 10.0% |
| Total | $25.20 avg | 5,651 | $142K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |